Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15087342.
- Also identified by PMC identifier 390215.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
What role do selective serotonin reuptake inhibitors have in treating psychiatric morbidity in patients with cardiovascular disease? This review discusses the safety and efficacy of various antidepressants in this group of patients and their potential for improving cardiovascular outcomes
Medical subject headings
- Anxiety Disorders
- Cardiovascular Diseases
- Depressive Disorder